Aug 4 2020 - Phase 3 Trials And More
Summary MRNA, PFE/BNTX, and AZN are leading the three vaccines in clinical phase 3 trials. Vaccines developed using different vectors have differen...
Summary MRNA, PFE/BNTX, and AZN are leading the three vaccines in clinical phase 3 trials. Vaccines developed using different vectors have differen...
Moderna CEO Stéphane Bancel more than tripled the number of his company shares to be sold through an executive stock plan that was changed just days ...
ALEX HOGAN/STAT A30,000-patient trial of Moderna’s coronavirus vaccine candidate, expected to start next week, has been delayed, a potential hurd...
Summary Moderna shared encouraging clinical results data. Study and its limitations explained. Investors may fret over the company selling shares a...
Summary Novavax is trouncing Moderna in total stock return terms. Novavax animal models analyzed. Price targets on Novavax and Moderna reviewed. We...
Summary Insider buying decreased significantly last week. Notable Insider Buys: Mercury General Corporation, Cortexyme, Inc., New Mountain Finance ...
Though big-ticket spending and small-business loans provide short-term relief, investors say a coronavirus remedy is the No.1 go-ahead signal they’re ...